СИНДРОМ ИЗБЫТОЧНОГО БАКТЕРИАЛЬНОГО РОСТА В КЛИНИЧЕСКОЙ ПРАКТИКЕ
Аннотация
Обзорная статья посвящена проблеме синдрома избыточного бактериального роста (СИБР). Даны определения синдрома, эпидемиология, клинические проявления, диагностика. Рассмотрены вопросы патогенеза и связь СИБР с заболеваниями желудочно-кишечного тракта. Приведены новые исследования по изучению СИБР у больных воспалительными заболеваниями кишечника.
Об авторах
Т. Б. Топчий
ФГБУ ДПО «ЦГМА» УДПРФ
Россия
Россия
О. Н. Минушкин
ФГБУ ДПО «ЦГМА» УДПРФ
Россия
Россия
Ю. С. Скибина
ФГБУ ДПО «ЦГМА» УДПРФ
Россия
Россия
А. Е. Евсиков
ФГБУ ДПО «ЦГМА» УДПРФ
Россия
Россия
Список литературы
1. Ардатская М. Д. Синдром избыточного бактериального роста и нарушение процессов пищеварения и всасывания: патогенетическая нутриционная терапия//. Экспериментальная и клиническая гастроэнтерология. 2009; 6; С. 86-96.
2. Ардатская М. Д., Минушкин О. Н. Синдром избыточного бактериального роста: определение, современные подходы к диагностике и лечебной коррекции.// Гастроэнтерология. 2012; 2: С. 45-49
3. Ардатская М. Д. Синдром избыточного бактериального роста в тонкой кишке, современные методы диагностики и подходы к лечебной коррекции. //Медицинский совет 2016, 14: 88-95.
4. Белоусова Е. А. Синдром избыточного бактериального роста тонкой кишки в свете общей концепции о дисбактериозе кишечника. Взгляд на проблему. //Фарматека, 2009, № 2.
5. Логинов В.А. кандид. Дисс. Синдром избыточного бактериального роста у больных со сниженной кислотопродуцирующей функции желудка (клиническое значение, диагностика и лечение). М. 2015.
6. Almeida J. A., Kim R., Stoita A., McIver C.J., Kurtovic J., Riordan S. M. Lactose malabsorption in the elderly: role of small intestinal bacterial overgrowth. Scand. J. Gastroenterol. 2008;43(2): 146-54.
7. Bures J, Cyrany J, Kohoutova D, Fo¨ rstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol WJG 2010;16:2978-90.
8. Carrara M., Desideri S., Azzurro M., Bulighin G. M. et al. Small intestine bacterial overgrowth in patients with irritablebowel syndrome. Eur. Rev. Med. Pharmacol. Sci. 2008 May-Jun;12(3):197-202.
9. Castiglione F, Del Vecchio Blanco G, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn’s disease. J Clin Gastroenterol. 2000;31:63-66.
10. Chandra S, Dutta U, Noor MT, Taneja N, Kochhar R, Sharma M, et al. Endoscopic jejunal biopsy culture: a simple and effective method to study jejunal microflora. Indian J Gastroenterol 2010;29:226-30.
11. Chang MS, Green PHR. A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease. Ther Adv Gastroenterol 2012;5:31-6.
12. Chang MS, Minaya MT, Cheng J, Connor BA, Lewis SK, Green PHR. Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. Dig Dis Sci 2011;56:2939-46.
13. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR, Harmsen WS, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011;33:1059-67.
14. Collins BS, Lin HC. Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation. Dig Dis Sci 2010;55: 124-30.
15. Collins BS, Lin HC. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. J Pediatr Gastroenterol Nutr 2011;52:382-6.
16. Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 2011;41:380-6.)
17. Daveson AJM, Anderson RP. Small bowel endoscopy and coeliac disease. Best Pract Res Clin Gastroenterol 2012;26:315-23.
18. Dominguez-Munoz J. E. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr. Gastroenterol Rep. 2007
19. Fairris GM, Ashworth J, Cotterill JA. A dermatosis associated with bacterial overgrowth in jejunal diverticula. Br J Dermatol 1985;112:709-13.
20. Fundaro` C, Fantacci C, Ansuini V, Giorgio V, Filoni S, Barbaro F, et al. Fecal calprotectin concentration in children affected by SIBO. Eur Rev Med Pharmacol Sci 2011;15:1328-35.
21. George N.S,. Sankineni A., Parkman H.P. Small Intestinal Bacterial Overgrowth in Gastroparesis Dig Dis Sci. 2012. Oct 5.
22. Ghoshal UC. How to interpret hydrogen breath tests. J Neurogastroenterol Motil 2011;17:312-7.
23. Ghoshal UC, Kumar S, Mehrotra M, Lakshmi C, Misra A. Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil 2010;16:40-6.
24. Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010;53:849-55.
25. Hutyra T, Iwan´ czak B. Bakteryjny przerost flory jelita cienkiego u dzieci Small bowel bacterial overgrowth in children Pediatr Wspo´ łczesna Gastroenterol Hepatol Z˙yw Dziecka 2010;12:130-4.
26. Jouet P, Coffin B, Sabate J-M. Small intestinal bacterial overgrowth in patients with morbid obesity. Dig Dis Sci 2011;56:615. author reply 615-616.
27. Jun DW, Kim KT, Lee OY, Chae JD, Son BK, Kim SH, et al. Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci 2010;55:1465-71.
28. Kim K-M, Kim B-T, Lee D-J, Park S-B, Joo N-S, Kim Y-S, et al. Erosive esophagitis may be related to small intestinal bacterial overgrowth. Scand J Gastroenterol 2012;47:493-8.
29. Lappinga PJ, Abraham SC, Murray JA, Vetter EA, Patel R, Wu T-T. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med 2010; 134: 264-70.
30. Lakshmi CP, Ghoshal UC, Kumar S, Goel A, Misra A, Mohindra S, et al. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction. Dig Dis Sci 2010;55:1142-8.
31. Leiby A, Mehta D, Gopalareddy V, Jackson-Walker S, Horvath K. Bacterial overgrowth and methane production in children with encopresis. J Pediatr 2010;156:766-70. 770.e1.
32. Leung Ki EL, Roduit J, Delarive J, Guyot J, Michetti P, Dorta G. Small intestine bacterial overgrowth. Rev Me´ dicale Suisse 2010;6:186-8. 190-1.
33. Łokiec´ K, Klupin´ska G, Walecka-Kapica E, Błon´ ska A. Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome. Pol Merkur Lek Organ Pol Tow Lek 2014;36: 307-10.
34. Lin H. C. Small intestinal bacterial overgrowth: aframework for understanding irritable bowel syndrome.JAMA. 2004. Aug 18; 292(7): 852-8.
35. Lisowska A, Pogorzelski A, Oracz G, Skorupa W, Cofta S, Socha J, et al. Small intestine bacterial overgrowth and fat digestion and absorption in cystic fibrosis patients. Acta Sci Pol Technol Aliment 2010;9:477-83.
36. Lisowska A, Wo´ jtowicz J, Walkowiak J. Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection. Acta Biochim Pol 2009;56:631-4.
37. Lisowska A, Pogorzelski A, Oracz G, Siuda K, Skorupa W, Rachel M, et al. Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cyst Fibros 2011;10:418-21.
38. Lombardo L., Foti M., Ruggia O., Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy Clin. Gastroenterol. Hepatol. 2010.Jun;8(6): 504-8.
39. Madrid AM, Poniachik J, Quera R, Defilippi C. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci 2011;56:155-60.
40. Miazga A. et al. / Advances in Medical Sciences 60 (2015) 118-124
41. Mitchell DM, Henao MP, Finkelstein JS, Burnett-Bowie S-AM. Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract 2012;18: 914-23.
42. Ojetti V, Pitocco D, Scarpellini E, Zaccardi F, Scaldaferri F, Gigante G, et al. Small bowel bacterial overgrowth and type 1 diabetes. Eur Rev Med Pharmacol Sci 2009;13:419-23.
43. Pande C., Kumar A., Sarin S. K. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver diseaseAliment Pharmacol Ther. 2009. Jun 15; 29(12): 1273-81.
44. Park JS, Yu JH, Lim HC, Kim JH, Yoon YH, Park HJ, et al. Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome. Korean J Gastroenterol Taehan Sohwagi Hakhoe Chi 2010;56:242-8.
45. Parodi A, Sessarego M, Greco A, Bazzica M, Filaci G, Setti M, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008;103:1257-62.
46. Pimentel M. Evaluating a bacterial hypothesis in IBS using a modification of Koch’s postulates: part 1. Am J Gastroenterol 2010;105:718-21.
47. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci. 2003;48:86-92.
48. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012;57:1321-9.
49. Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion 2012;85:243-7.
50. Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther 2011;13:1115-20.
51. Rana SV, et al. Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel DiseaseDig Dis Sci (2013) 58:2594-2598).
52. Rana SV, et al. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients, J Crohns Colitis (2014).
53. Ratuapli SK, Ellington TG, O’Neill M-T, Umar SB, Harris LA, Foxx-Orenstein AE, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol 2012;107:730-5.
54. Romond M-B, Colavizza M, Romond PC, Bezirtzoglou E. Selective decontamination by antimicrobials during long term treatment: perspectives for saving host indigenous microbiota. Anaerobe 2011;17:468-73.
55. Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol 2011;26(Suppl. 3):135-8.
56. Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013;4:223-31.
57. Schommer K, Reljic D, Ba¨rtsch P, Sauer P. Gastrointestinal complaints in runners are not due to small intestinal bacterial overgrowth. J Negat Results Biomed 2011;10:8.
58. Singh, V. V., Toskes, P. P. Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment // Curr Treat Options Gastroenterol. 2004; 7 (1): 19-28.
59. Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 2010;55:2441-9.
60. Spiegel BMR. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastro-enterol Hepatol 2011;9:461-9. quiz e59.
61. Tarnopolsky MA, Pearce E, Matteliano A, James C, Armstrong D. Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. Muscle Nerve 2010;42:853-5.
62. Shanab AA, Scully P, Crosbie O, Buckley M, O’Mahony L, Shanahan F, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 2011;56:1524-34.
63. Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med 2011;12:610-3.
64. Wilder-Smith CH, Materna A, Wermelinger C, Schuler J. Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther2013;37:1074-83.
65. Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol 2011;17:371-5.
66. Zhao J, Fox M, Cong Y, Chu H, Shang Y, Fried M, et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2010;31:892-900.
67. Zoetendal EG, Raes J, van den Bogert B, Arumugam M, Booijink CCGM, Troost FJ, et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 2012;6:1415-26.
Для цитирования:
Топчий Т.Б., Минушкин О.Н., Скибина Ю.С., Евсиков А.Е. СИНДРОМ ИЗБЫТОЧНОГО БАКТЕРИАЛЬНОГО РОСТА В КЛИНИЧЕСКОЙ ПРАКТИКЕ. Экспериментальная и клиническая гастроэнтерология. 2017;(3):71-78.
For citation:
Topchy T.B., Minushkin O.N., Skibina Y.S., Evsikov A.E. THE BACTERIAL OVERGROWTH SYNDROME IN CLINICAL PRACTICE. Experimental and Clinical Gastroenterology. 2017;(3):71-78. (In Russ.)
Просмотров: 41
Послать статью по эл. почте 